ClinicalTrials.Veeva

Menu

Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid Study (iCARE Plus)

Northwestern University logo

Northwestern University

Status

Enrolling

Conditions

Adolescent HIV Infection

Treatments

Behavioral: Social Media Outreach
Behavioral: Treatment Peer Navigation
Behavioral: Testing Peer navigation
Behavioral: PrEP Intervention
Other: Adherence standard of care
Behavioral: SMS Test messaging

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06880224
iCARE Plus
UG1HD113160 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Two combination interventions (HIV Case Finding Intervention and HIV Treatment Intervention), each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria.

Full description

Two combination interventions, each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria:

  1. HIV Case Finding Intervention: single arm trial of an HIV case finding and linkage to care intervention targeting young men at risk of HIV infection (n = 6000), particularly young men who have sex with men (YMSM) in Akwa Ibom, Benue, Enugu, Kano, Taraba, and Lagos states who complete HIV testing.

    Objectives: To determine the effectiveness of the intervention to:

    • identify youth living with HIV, particularly YMSM and
    • link those who test HIV-positive to HIV care
    • pre-exposure prophylaxis (PrEP) initiation (uptake) among those who test HIV-negative.
  2. HIV Treatment Intervention: randomized controlled trial of a medication adherence and viral suppression intervention among youth newly diagnosed with HIV and initiating antiretroviral therapy (ART) for the first time (n = 600) at the participating clinical sites.

Objectives: To determine the effectiveness of the intervention on

  • viral suppression and
  • adherence to ART
  • success of implementation in the target populations

Enrollment

500 estimated patients

Sex

All

Ages

15 to 24 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

HIV Case Finding Intervention:

  • Aged 15 to 24
  • Male birth sex of any current gender identity
  • Understand basic English, Yoruba, Hausa, Igbo or Pidgin English For the PrEP component, must also be HIV-negative

HIV Treatment Intervention:

  • Aged 15 to 24
  • HIV seropositive
  • Initiating ART for the first time at a Clinical Research Performance Site (CRPS) clinic or satellite clinic
  • Understand basic English, Yoruba, Hausa, Igbo or Pidgin English
  • Intention to remain a CRPS patient during follow-up

Exclusion criteria

  • Unable to provide consent
  • No parental permission if aged 15 and not emancipated

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

500 participants in 2 patient groups

HIV Case Finding Intervention
Experimental group
Description:
Combination HIV case finding and linkage to care intervention
Treatment:
Behavioral: PrEP Intervention
Behavioral: Testing Peer navigation
Behavioral: Social Media Outreach
HIV Treatment Intervention
Experimental group
Description:
Combination HIV treatment intervention vs. standard of care adherence among youth newly diagnosed with HIV and initiating ART
Treatment:
Behavioral: SMS Test messaging
Other: Adherence standard of care
Behavioral: Treatment Peer Navigation

Trial contacts and locations

6

Loading...

Central trial contact

Lisa M Kuhns, PhD; Robert Garofalo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems